Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 2,665.00
-90.00 (-3.27%)
Aug 12, 2026, 1:55 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 125.3 billion as of August 11, 2026. Its market cap has decreased by -44.73% in one year.
Market Cap
125.30B
Enterprise Value
n/a
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,665.00
ChartMarket Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 125.30B, an increase of 14.93%. That is a compound annual growth rate of 0.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 123.70B | -41.94% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 188.38B |
| Bioneer | 178.35B |
| Anterogen.Co.,Ltd. | 169.40B |
| JETEMA, | 162.20B |
| Helixmith | 156.56B |
| NeoImmuneTech | 151.17B |
| Macrogen | 133.57B |
| Vaxcell-Bio Therapeutics | 96.98B |